Svas Biosana S.p.A. (BIT:SVS)
Italy flag Italy · Delayed Price · Currency is EUR
8.16
-0.02 (-0.24%)
At close: Aug 8, 2025, 5:30 PM CET

Svas Biosana Revenue

In the year 2024, Svas Biosana had annual revenue of 122.29M EUR with 0.54% growth. Svas Biosana had revenue of 63.25M in the half year ending December 31, 2024, with 15.37% growth.

Revenue
122.29M
Revenue Growth
+0.54%
P/S Ratio
0.36
Revenue / Employee
373.97K
Employees
327
Market Cap
43.68M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024122.29M656.90K0.54%
Dec 31, 2023121.63M22.12M22.22%
Dec 31, 202299.51M17.52M21.37%
Dec 31, 202181.99M4.72M6.11%
Dec 31, 202077.27M-23.22M-23.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Recordati Industria Chimica e Farmaceutica 2.48B
DiaSorin 1.22B
Amplifon 2.41B
EL.En. 577.19M
Philogen 77.65M
Safilo Group 998.89M
GPI S.p.A. 509.93M
Pharmanutra 116.15M
Revenue Rankings